Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine Medical Center, Orange, California, USA.
World Neurosurg. 2020 Dec;144:e546-e552. doi: 10.1016/j.wneu.2020.08.227. Epub 2020 Sep 8.
OBJECTIVES: Esthesioneuroblastoma (ENB) is a rare sinonasal malignancy arising from olfactory neuroepithelium. Recurrence typically occurs locoregionally at the primary site or in the form of cervical metastasis. Delayed local recurrence away from the initial primary site is exceedingly rare. METHODS: Retrospective review of 4 patients with histologically confirmed extraprimary local recurrence of ENB was performed with review of the literature. RESULTS: All cases initially presented with ENB isolated to the cribriform plate(s) treated with primary surgical resection and adjuvant radiotherapy. The first patient had ENB recurrence 8 years posttreatment involving the right orbit. She later developed metastases to the spine, neck, and mandible requiring composite resection and 4 courses of radiotherapy. The second patient had ENB recurrence of the dorsal septum 9 years posttreatment with cervical metastases requiring septectomy, bilateral neck dissection, and radiotherapy. The third patient had ENB recurrence 7 years posttreatment in the posterior nasopharynx requiring endonasal nasopharyngectomy. Finally, the fourth patient had ENB recurrence 12 years posttreatment in the sphenopalatine foramen, which was endoscopically resected. At the time of this review, all 4 patients were disease free at 32, 21, 4, and 24 months posttreatment follow-ups, respectively. CONCLUSIONS: This case series describes the rare phenomenon of delayed extraprimary local recurrence of histologically confirmed ENB. Treatment of extraprimary recurrences, analogous to other forms of ENB, should include primary surgical resection with adjuvant radiotherapy for generally favorable outcomes. Long-term close follow-up based on symptoms, endoscopy, and imaging is essential because of the risk of delayed recurrence.
目的:嗅神经母细胞瘤(ENB)是一种罕见的起源于嗅神经上皮的鼻腔鼻窦恶性肿瘤。复发通常发生在原发部位的局部或颈部转移。远离初始原发部位的延迟局部复发极为罕见。
方法:对 4 例经组织学证实的嗅神经母细胞瘤原发部位以外局部复发的患者进行回顾性分析,并对文献进行回顾。
结果:所有病例均表现为孤立于筛板的嗅神经母细胞瘤,采用原发手术切除和辅助放疗治疗。第一例患者在治疗后 8 年出现涉及右侧眼眶的 ENB 复发。她后来发展为脊柱、颈部和下颌骨转移,需要进行复合切除术和 4 个疗程的放疗。第二例患者在治疗后 9 年出现鼻中隔后部的 ENB 复发,伴有颈部转移,需要行鼻中隔切除术、双侧颈部淋巴结清扫术和放疗。第三例患者在治疗后 7 年出现后鼻咽部的 ENB 复发,需要进行经鼻内镜鼻咽切除术。最后,第四例患者在治疗后 12 年出现蝶腭孔的 ENB 复发,经内镜切除。在本次回顾时,这 4 例患者的无病生存时间分别为治疗后 32、21、4 和 24 个月。
结论:本病例系列描述了罕见的组织学证实的嗅神经母细胞瘤原发部位以外的延迟局部复发现象。类似其他类型的嗅神经母细胞瘤,治疗原发部位以外的复发应包括原发手术切除和辅助放疗,通常预后良好。由于存在延迟复发的风险,需要根据症状、内镜和影像学进行长期密切随访。
World Neurosurg. 2020-12
Kulak Burun Bogaz Ihtis Derg. 2012
Clin Neurol Neurosurg. 2015-11
Laryngoscope. 2016-7
Eur Arch Otorhinolaryngol. 2014-12
Cancers (Basel). 2023-2-28